Human allograft acceptance is associated with immune regulation

The ultimate goal of transplantation is drug-free allograft acceptance, which is rarely encountered in transplant recipients. Using a novel human-to-mouse "trans vivo" delayed-type hypersensitivity assay, we assessed donor-reactive cell-mediated immune responses in kidney and liver transpl...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of clinical investigation 2000-07, Vol.106 (1), p.145-155
Main Authors: VanBuskirk, A M, Burlingham, W J, Jankowska-Gan, E, Chin, T, Kusaka, S, Geissler, F, Pelletier, R P, Orosz, C G
Format: Article
Language:English
Subjects:
Animals
Histocompatibility Testing
HLA-A Antigens - immunology
HLA-DR Antigens - immunology
Humans
Hypersensitivity, Delayed - etiology
Interleukin-10 - physiology
Kidney Transplantation - immunology
Liver Transplantation - immunology
Mice
Mice, SCID
Rabbits
Transforming Growth Factor beta - physiology
Transplantation, Homologous
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The ultimate goal of transplantation is drug-free allograft acceptance, which is rarely encountered in transplant recipients. Using a novel human-to-mouse "trans vivo" delayed-type hypersensitivity assay, we assessed donor-reactive cell-mediated immune responses in kidney and liver transplant patients, four of whom discontinued all immunosuppression. One of these subjects (J.B.) rejected his graft after 7 years of stable function, while the others (D.S., R.D., M.L.) continue to have excellent graft function 5, 28, and 4 years after the cessation of immunosuppression. PBMCs from J.B. exhibited strong responses to both donor and recall antigens whereas PBMCs from patients D.S., R.D., and M.L. responded strongly to recall, but not donor, antigens. Furthermore, when donor and recall antigens were colocalized, the recall response in these three patients was inhibited. This donor antigen-linked nonresponsiveness was observed in four other patients who are still maintained on immunosuppression. The weakness of donor-reactive DTH responses in these patients is due to donor alloantigen-triggered regulation that relies on either TGF-beta or IL-10. In D.S., regulation is triggered by a single donor HLA Class I antigen, either in membrane-bound or soluble form. This demonstrates that allograft acceptance in humans is associated with an immune regulation pattern, which may be useful in the diagnosis and/or monitoring of transplant patients for allograft acceptance.
ISSN:0021-9738
DOI:10.1172/JCI9171